Filter
572
Text search:
pipeline
Featured
Recommendations
66
New Publications
155
Language
Document type
No document type
252
Studies & Reports
119
Guidelines
80
Strategic & Response Plan
42
Manuals
32
Situation Updates
17
Fact sheets
14
Resource Platforms
5
Infographics
3
Videos
3
Training Material
2
Online Courses
2
Brochures
1
Countries / Regions
Global
26
South Sudan
16
Kenya
15
Ethiopia
14
India
13
Syria
13
South Africa
13
Ukraine
12
Africa
12
Nigeria
11
Mozambique
10
Sierra Leone
9
Uganda
9
East and Southern Africa
9
Nepal
8
Rwanda
8
Liberia
7
Haiti
7
Myanmar / Burma
7
Zambia
6
Bangladesh
6
Malawi
6
Yemen
6
Latin America and the Carribbean
6
Tanzania
5
West and Central Africa
5
China
4
Asia
4
Guinea
3
Congo, Democratic Republic of
3
USA
3
Philippines
3
Sudan
3
South–East Asia Region
3
Eastern Europe
3
Burkina Faso
2
Jordan
2
Turkey
2
Indonesia
2
Central African Republic
2
Brazil
2
Burundi
2
Botswana
2
Western and Central Europe
2
Albania
2
Russia
2
Moldova
2
Senegal
1
Mali
1
Côte d’Ivoire / Ivory Coast
1
Saudi Arabia
1
Cameroon
1
Ghana
1
Zimbabwe
1
Somalia
1
Pakistan
1
Thailand
1
Singapore
1
Benin
1
Namibia
1
Eswatini/ Swaziland
1
Serbia
1
Hungary
1
Colombia
1
Ecuador
1
Angola
1
Sri Lanka
1
Middle East and North Africa
1
Western Pacific Region
1
Bhutan
1
Venezuela
1
Poland
1
Italy
1
Southern Africa
1
Laos
1
Qatar
1
Romania
1
Vietnam
1
Portugal
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
179
Clinical Guidelines
42
Key Resources
29
Pharmacy & Technologies
26
Public Health
18
Women & Child Health
12
Capacity Building
3
Annual Report MEDBOX
1
Toolboxes
COVID-19
74
AMR
71
TB
50
HIV
45
Conflict
42
Natural Hazards
23
NTDs
20
Planetary Health
16
Pharmacy
12
Ebola
10
Health Financing Toolbox
10
Rapid Response
8
Mental Health
7
Specific Hazards
7
Global Health Education
4
Caregiver
4
Cholera
3
Refugee
3
Zika
3
Disability
2
Typhoon
2
Polio
1
Social Ethics
1
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spr
...
Drugs, Diagnostics, Vaccines, Preventive Technologies, Research toward a cure, and immune-based and gene therapies in development
This report presents an analysis of antibacterial agents in preclinical (third annual review) and clinical (fifth annual review) development. The analysis covers traditional (direct-acting small molecules) and non-traditional antibacterial agents in development worldwide. It evaluates to what extent
...
Many in-house and commercial assays that detect the COVID-19 virus have been developed or are currently under development. Many of these molecular assays are currently being validated in partner laboratories. An overview of assays that have applied to FIND for participation in their assay assessment
...
A guidebook intended for use by first responders
during the initial phase of a transportation incident
involving dangerous goods/hazardous materials
htb supplement: 2018 Vol 19:(1)
New drugs in development
July 2018
www.i-Base.info
The pre-clinical pipeline shows more innovation and diversity, with 252 agents being developed to treat WHO priority pathogens.
However, these products are in the very early stages of development and still need to be proven effective and safe. Th
...
This tracker, developed by the Vaccine Centre at the London School of Hygiene & Tropical Medicine, will follow COVID-19 vaccine candidates as they progress through the development pipeline. We will update it weekly. An overview of the different vac
...
3 March 2016
The USAID | DELIVER PROJECT, Task Order 4, developed this guide for quantifying health commodities; it will assist technical advisors, program managers, warehouse managers, procurement officers, and service providers in (1) estimating the total commodity needs and costs for successful implementation
...
How to address the global crisis in antibiotic research and development.
The report includes a comprehensive summary and critical evaluation of recent initiatives to overcome the barriers to achieve sustainable access to antibiotics. As antibiotic resistance will continue to develop as long as we
...
Globally each year, millions of people suffer illness or lose their lives because the vaccines, medicines and diagnostic tests that they need are either unavailable or unaffordable – and this lack of access to medicine is acute in low- and middle-in-
come countries (LMICs). While the COVID-19 pan
...
Semi-annual Update
29 April 2022
What are the new vaccines in the pipeline? What are the challenges to turning vaccines into vaccination ? What timelines can we expect for future vaccines? WHO’s Dr Katherine O’Brien explains in Science in 5.
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i
...
Fever Diagnostic Technology Landscape
recommended
1st edition.
Unitaid’s report describes a slate of new devices that can more efficiently identify dangerously ill children so that they can be treated immediately. These tools make it easier to recognize danger signs, and support integrated approaches to reducing childhood deaths from the three
...
The roadmap describes the actions needed to
achieve the three development goals for TB
vaccines set by the WHO:
1. A safe, effective and affordable TB vaccine
for adolescents and adults.
2. An affordable TB vaccine for neonates and
infants with improved safety and efficacy.
3. A therapeutic v
...
